Valeant Pharmaceuticals International Inc said its discount and rebates program for two high-priced heart drugs would cover over 90 percent U.S. hospitals once it had finalized the last of the 14 group purchasing organizations. Valeant’s statement comes after Bloomberg reported that some medical centers had yet to see a cent ... Read More »

Drugmaker Valeant Pharmaceuticals International Inc (VRX.TO)(VRX.N) said on Monday its chief executive officer is leaving and billionaire investor William Ackman would join the board as it tries to clean up accounting problems and save its business. The company, whose operations include prescription drugs, consumer products, and Bausch & Lomb eye ... Read More »